The interactions here described are in agreement with a model in which molecular structure of DRB1-DQB1 alleles constituting the genotype modulates the MS risk through a synergic action of molecules permissive or not-permissive for the same or different MBP epitopes or perhaps for different autoantigens. The gene discussed is HLA-DRB1; the disease is myeloid sarcoma.